skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Can you please comment on the recent earnings release? Also would you consider it a buy, sell, or hold? Thanks
Read Answer Asked by sean on August 18, 2015
Q: Trying to decide on merus or pli prometic for investment,
would like your opinion.
Thanks.
Read Answer Asked by howard on August 17, 2015
Q: What is your view on this one? Is it expensive? After its QR, do you like this one or GUD moving forward? Is GUD expensive?
Read Answer Asked by Louis on August 17, 2015
Q: Hi,

Do you have any comments on NHC earnings this morning?

Thanks
Read Answer Asked by Charles on August 14, 2015
Q: can you please comment on Concordia Q2 results issued yesterday? Is this a good time to invest more as I am underallocated in the sector? thanks again and again! John
Read Answer Asked by john on August 14, 2015
Q: Hi team, yesterday you said this to Rebecca: "Right now, we think investors are selling 'because it is down' and for no other reason, which is generally (if not always) the wrong reason to sell."....so would you recommend buying to average down? Also do you know when is the Investor Presentation and do you think it will finally help the share price?
Thank you!
Read Answer Asked by Silvia on August 14, 2015
Q: I haven't been interested in Patient Home Monitoring PHM, until now, because of the price drop. What does PHM mean when they describe themselves as "focused on rolling-up annuity-based healthcare service companies..."? I believe that "rolling-up" means buying and consolidating companies. But what do they mean by "annuity-based"? I googled the term and there's virtually nothing except the quote I just gave.Thanks!
Read Answer Asked by Jerry on August 12, 2015
Q: There is relentless selling going on with PHM, and it seems there is no bottom for it. There are 46 millions of shares financed at $1.50 will come to free trade in September. Do you think PHM will be under more pressure around that time? Should investors just take a loss and move on? Do you know any company can make a turn around like this from your past experience?

Read Answer Asked by Rebecca on August 12, 2015
Q: Hi Peter and Team,

Please comment on the results out of GUD this am.

In general what numbers do you look at in quarterly reports?

Thank you
Read Answer Asked by David on August 12, 2015
Q: Hello team, GUD just reported earnings....your comments pls.
Thank you.
Read Answer Asked by Silvia on August 12, 2015
Q: I recently bought the following health care stocks: Merus, NHC, PHM and CRH Medical and they are all down a lot now, some as much as 40%. I’m not sure whether I should sell and take the losses or hold on? And why is health care selling off? I thought it usually did well in a recession?
Read Answer Asked by Carla on August 12, 2015
Q: Do you have an opinion on the outlook for Regeneron?

Thanks
Read Answer Asked by Richard on August 12, 2015
Q: Hi folks,if no one else has asked,could please comment on Q results for Merus labs & going forward,would u rate it a buy,hold or sell. If already asked,please disregard,thanks, jb
Read Answer Asked by John on August 11, 2015
Q: Hi if CRH wants to roll up anesthesia services who else is in the same space?
Thanks.
Read Answer Asked by Mike on August 11, 2015
Q: Hi Peter,
What is phm price going to move after the company holds meetings with institutional investors.
Thanks, Jim
Read Answer Asked by Jim on August 11, 2015
Q: Hi Peter,

I see a lot of bio/medical service stocks are being taken to the woodshed today for reasons unknown. I plan on selling a bit of AYA and building my holding in GUD to a full position (5.1% of my total portfolio) and then not touching it for at least 3 years. What do you think?

Thanks

Peter
Read Answer Asked by Peter on August 07, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!